Form: 10-K

Annual report pursuant to Section 13 and 15(d)

March 21, 2022

 

Exhibit 21.1

 

Lixte Biotechnology Holdings, Inc.

Subsidiaries as of December 31, 2021

 

Subsidiary Name   Jurisdiction of Incorporation   Percentage Owned
Lixte Biotechnology, Inc.   Delaware.   100%